Allergan plc (AGN.N) News| Reuters.com
Edition:
United States

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

230.55USD
29 Jun 2016
Change (% chg)

$2.83 (+1.24%)
Prev Close
$227.72
Open
$230.80
Day's High
$234.51
Day's Low
$227.80
Volume
772,431
Avg. Vol
683,513
52-wk High
$340.33
52-wk Low
$195.51

Select another date:

Tue, Jun 21 2016

Photo

Impax buys generic drugs from Teva, Allergan for $586 million

Impax Laboratories Inc said it would buy a portfolio of generic drugs from Teva Pharmaceutical Industries Ltd and Allergan Plc for about $586 million.

UPDATE 2-Impax buys generic drugs from Teva, Allergan for $586 mln

June 21 Impax Laboratories Inc said it would buy a portfolio of generic drugs from Teva Pharmaceutical Industries Ltd and Allergan Plc for about $586 million.

BRIEF-Impax signs agreements to acquire generic products from Teva, Allergan

* Expects 2016 total company revenues to increase at least 15% over full year 2015

Impax buys portfolio of generic products from Teva, Allergan

June 21 Impax Laboratories Inc said it would buy a portfolio of generic products from Teva Pharmaceutical Industries Ltd and Allergan Plc for about $586 million.

BRIEF-Allergan says FDA accepts premarket notification filing for glaucoma treatment

* "Look forward to working together with FDA" to bring glaucoma treatment system to market

India's Dr Reddy's in $350 million deal to buy eight U.S. drugs from Teva, Allergan

MUMBAI India's second-largest drugmaker Dr Reddy's Laboratories Ltd said it agreed to buy eight generic drugs from Teva Pharmaceutical Industries and Allergan Plc for $350 million in cash to bolster its U.S. business.

CORRECTED-UPDATE 1-India's Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan

MUMBAI, June 11 India's second-largest drugmaker Dr Reddy's Laboratories Ltd said it agreed to buy eight generic drugs from Teva Pharmaceutical Industries and Allergan Plc for $350 million in cash to bolster its U.S. business.

CORRECTED-India's Dr Reddy's to buy 8 U.S. generic drugs from Teva, Allergan for $350 mln

MUMBAI, June 11 India's No. 2 drugmaker Dr Reddy's Laboratories Ltd said it agreed to buy a portfolio of eight generic drugs from Teva Pharmaceutical Industries Ltd and Allergan Plc for $350 million in cash to bolster its U.S. business.

BRIEF-Allergan says supplemental NDA for 72 mcg Linaclotide accepted for FDA review

* FDA prescription drug user fee act (PDUFA) target action date is expected to occur in early 2017

BRIEF-Allergan CEO to CNBC: "Don't know exactly" how large Icahn's position in the company is

* Allergan CEO to CNBC: "Don't know exactly" how large Icahn's position in the company is

Select another date: